Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumors

Amit Hagar, Zemin Wang, Sachiko Koyama, Josua Aponte Serrano, Luma Melo, Stephanie Vargas, Richard Carpenter, John Foley

Research output: Contribution to journalArticle

Abstract

Background: Aerobic exercise has been shown to slow tumor progression in rodents and humans, but the mechanisms behind this effect are still unclear. Here we show that aerobic exercise in the form of chronic endurance training suppresses tumor recruitment of FoxP3+ Treg cells thus enhancing antitumor immune efficiency. Methods: Adult wild-type and athymic BALB/c female mice were endurance-trained for 8 weeks. Circulating leukocytes as well as muscle and liver mtDNA copy number were compared to aged-matched concurrent sedentary controls to establish systemic effects. 4 T1 murine mammary tumor cells were injected subcutaneously to the 4th mammary pad at the end of the training period. Tumor growth and survival rates were compared, together with antitumor immune response. Results: Exercised wild-type had 17% slower growth rate, 24% longer survival, and 2-fold tumor-CD+ 8/FoxP3+ ratio than sedentary controls. Exercised athymic BALB/c females showed no difference in tumor growth or survival rates when compared to sedentary controls. Conclusions: Cytotoxic T cells are a significant factor in endurance exercise-induced suppression of tumor growth. Endurance exercise enhances antitumor immune efficacy by increasing intratumoral CD8+/FoxP3+ ratio.

Original languageEnglish (US)
Article number536
JournalBMC Cancer
Volume19
Issue number1
DOIs
StatePublished - Jun 4 2019

Fingerprint

Regulatory T-Lymphocytes
Breast Neoplasms
Growth
Neoplasms
Exercise
Mitochondrial DNA
Rodentia
Breast
Leukocytes
T-Lymphocytes
Muscles
Survival
Liver

Keywords

  • CD8/FoxP3 ratio
  • Endurance exercise
  • Forced running wheels
  • Hypoxia
  • Murine mammary tumor
  • Solid tumor progression
  • Treg cells

ASJC Scopus subject areas

  • Oncology
  • Genetics
  • Cancer Research

Cite this

Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumors. / Hagar, Amit; Wang, Zemin; Koyama, Sachiko; Serrano, Josua Aponte; Melo, Luma; Vargas, Stephanie; Carpenter, Richard; Foley, John.

In: BMC Cancer, Vol. 19, No. 1, 536, 04.06.2019.

Research output: Contribution to journalArticle

Hagar, A, Wang, Z, Koyama, S, Serrano, JA, Melo, L, Vargas, S, Carpenter, R & Foley, J 2019, 'Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumors', BMC Cancer, vol. 19, no. 1, 536. https://doi.org/10.1186/s12885-019-5745-7
Hagar, Amit ; Wang, Zemin ; Koyama, Sachiko ; Serrano, Josua Aponte ; Melo, Luma ; Vargas, Stephanie ; Carpenter, Richard ; Foley, John. / Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumors. In: BMC Cancer. 2019 ; Vol. 19, No. 1.
@article{4fa39bbe74da4b859563726250f31797,
title = "Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumors",
abstract = "Background: Aerobic exercise has been shown to slow tumor progression in rodents and humans, but the mechanisms behind this effect are still unclear. Here we show that aerobic exercise in the form of chronic endurance training suppresses tumor recruitment of FoxP3+ Treg cells thus enhancing antitumor immune efficiency. Methods: Adult wild-type and athymic BALB/c female mice were endurance-trained for 8 weeks. Circulating leukocytes as well as muscle and liver mtDNA copy number were compared to aged-matched concurrent sedentary controls to establish systemic effects. 4 T1 murine mammary tumor cells were injected subcutaneously to the 4th mammary pad at the end of the training period. Tumor growth and survival rates were compared, together with antitumor immune response. Results: Exercised wild-type had 17{\%} slower growth rate, 24{\%} longer survival, and 2-fold tumor-CD+ 8/FoxP3+ ratio than sedentary controls. Exercised athymic BALB/c females showed no difference in tumor growth or survival rates when compared to sedentary controls. Conclusions: Cytotoxic T cells are a significant factor in endurance exercise-induced suppression of tumor growth. Endurance exercise enhances antitumor immune efficacy by increasing intratumoral CD8+/FoxP3+ ratio.",
keywords = "CD8/FoxP3 ratio, Endurance exercise, Forced running wheels, Hypoxia, Murine mammary tumor, Solid tumor progression, Treg cells",
author = "Amit Hagar and Zemin Wang and Sachiko Koyama and Serrano, {Josua Aponte} and Luma Melo and Stephanie Vargas and Richard Carpenter and John Foley",
year = "2019",
month = "6",
day = "4",
doi = "10.1186/s12885-019-5745-7",
language = "English (US)",
volume = "19",
journal = "BMC Cancer",
issn = "1471-2407",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Endurance training slows breast tumor growth in mice by suppressing Treg cells recruitment to tumors

AU - Hagar, Amit

AU - Wang, Zemin

AU - Koyama, Sachiko

AU - Serrano, Josua Aponte

AU - Melo, Luma

AU - Vargas, Stephanie

AU - Carpenter, Richard

AU - Foley, John

PY - 2019/6/4

Y1 - 2019/6/4

N2 - Background: Aerobic exercise has been shown to slow tumor progression in rodents and humans, but the mechanisms behind this effect are still unclear. Here we show that aerobic exercise in the form of chronic endurance training suppresses tumor recruitment of FoxP3+ Treg cells thus enhancing antitumor immune efficiency. Methods: Adult wild-type and athymic BALB/c female mice were endurance-trained for 8 weeks. Circulating leukocytes as well as muscle and liver mtDNA copy number were compared to aged-matched concurrent sedentary controls to establish systemic effects. 4 T1 murine mammary tumor cells were injected subcutaneously to the 4th mammary pad at the end of the training period. Tumor growth and survival rates were compared, together with antitumor immune response. Results: Exercised wild-type had 17% slower growth rate, 24% longer survival, and 2-fold tumor-CD+ 8/FoxP3+ ratio than sedentary controls. Exercised athymic BALB/c females showed no difference in tumor growth or survival rates when compared to sedentary controls. Conclusions: Cytotoxic T cells are a significant factor in endurance exercise-induced suppression of tumor growth. Endurance exercise enhances antitumor immune efficacy by increasing intratumoral CD8+/FoxP3+ ratio.

AB - Background: Aerobic exercise has been shown to slow tumor progression in rodents and humans, but the mechanisms behind this effect are still unclear. Here we show that aerobic exercise in the form of chronic endurance training suppresses tumor recruitment of FoxP3+ Treg cells thus enhancing antitumor immune efficiency. Methods: Adult wild-type and athymic BALB/c female mice were endurance-trained for 8 weeks. Circulating leukocytes as well as muscle and liver mtDNA copy number were compared to aged-matched concurrent sedentary controls to establish systemic effects. 4 T1 murine mammary tumor cells were injected subcutaneously to the 4th mammary pad at the end of the training period. Tumor growth and survival rates were compared, together with antitumor immune response. Results: Exercised wild-type had 17% slower growth rate, 24% longer survival, and 2-fold tumor-CD+ 8/FoxP3+ ratio than sedentary controls. Exercised athymic BALB/c females showed no difference in tumor growth or survival rates when compared to sedentary controls. Conclusions: Cytotoxic T cells are a significant factor in endurance exercise-induced suppression of tumor growth. Endurance exercise enhances antitumor immune efficacy by increasing intratumoral CD8+/FoxP3+ ratio.

KW - CD8/FoxP3 ratio

KW - Endurance exercise

KW - Forced running wheels

KW - Hypoxia

KW - Murine mammary tumor

KW - Solid tumor progression

KW - Treg cells

UR - http://www.scopus.com/inward/record.url?scp=85066843497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066843497&partnerID=8YFLogxK

U2 - 10.1186/s12885-019-5745-7

DO - 10.1186/s12885-019-5745-7

M3 - Article

C2 - 31164094

AN - SCOPUS:85066843497

VL - 19

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

IS - 1

M1 - 536

ER -